Trade GALT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Galectin Therapeutics Inc. (GALT) is trading at US$3.93, up 1.03% today as of Sep 21, 14:13 EDT. The company has a market capitalisation of US$371.13M. Over the past 52 weeks, GALT has traded between US$2.03 and US$7.13. On Syfe you can trade GALT with $0 commission and add it to your watchlist.
| Previous close | US$3.89 |
|---|---|
| Market cap | US$371.13M |
| 52-week range | US$2.03 – US$7.13 |
| Volume | 1.07M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Galectin Therapeutics Inc.
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
Year: 2002
Galectin Therapeutics Says FDA Alignment Reached on Phase 3 Belapectin Trial
Jun 23, 12:44 PM · MT Newswires
Galectin Therapeutics Files $200 Million Mixed Shelf
Mar 31, 9:20 PM · MT Newswires
Galectin Therapeutics Inc. (GALT) stock is trading at US$3.93, +1.03% from the previous close of US$3.89.
The market cap for Galectin Therapeutics Inc. (GALT) stock is approximately US$371.13M.
The 52-week high for Galectin Therapeutics Inc. (GALT) stock is US$7.13.
The 52-week low for Galectin Therapeutics Inc. (GALT) stock is US$2.03.
Galectin Therapeutics Inc. (GALT) does not currently pay a dividend.
Stay on top of GALT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
